SCHEMBL25640277

SCHEMBL25640277

CNCC1(F)CCN(C(C)C)CC1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25481304 0.79 CYP2D6 (0.39) CYP2D6
SCHEMBL21451626 0.78 CYP2D6 (0.36) CYP2D6
SCHEMBL15739795 0.77 KDM1A (0.44)
SCHEMBL13741191 0.76 CYP2D6 (0.35) CYP2D6
SCHEMBL19756511 0.75 CYP2D6 (0.41) CYP2D6
SCHEMBL18068286 0.75 CYP2D6 (0.37) CYP2D6
SCHEMBL21648795 0.75
SCHEMBL803502 0.73 CYP2D6 (0.45) CYP2D6
SCHEMBL24758689 0.72 SLC6A2 (0.36) CYP2D6
SCHEMBL27012389 0.72 CYP2D6 (0.35) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104043-A1 ANTI-APOPTOTIC PROTEIN BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITION AND USES THEREOF 杭州和正医药有限公司 2023-06-15 WO disclosed